NexImmune, Inc. has announced the adjournment of its Special Meeting of Stockholders originally scheduled for July 11, 2024. The meeting has been rescheduled to July 19, 2024, and will be conducted virtually via live webcast. The purpose of the meeting is to seek stockholder approval for the proposed liquidation and dissolution of the company, as detailed in the Proxy Statement issued in June 2024. Stockholders of record as of June 11, 2024, are entitled to vote at the rescheduled meeting. NexImmune has provided various options for stockholders to submit their proxy votes, including over the Internet, by telephone, by mail, or during the live webcast of the meeting. Votes can be submitted until 11:59 p.m. Eastern Time on July 18, 2024. The company has engaged Laurel Hill Advisory Group, LLC to assist stockholders with voting and inquiries. NexImmune's management has expressed appreciation for stockholders' prompt attention and continued confidence.

NexImmune, Inc. has announced the adjournment of its Special Meeting of Stockholders originally scheduled for July 11, 2024. The meeting has been rescheduled to July 19, 2024, and will be conducted virtually via live webcast. The purpose of the meeting is to seek stockholder approval for the proposed liquidation and dissolution of the company, as detailed in the Proxy Statement issued in June 2024. Stockholders of record as of June 11, 2024, are entitled to vote at the rescheduled meeting. NexImmune has provided various options for stockholders to submit their proxy votes, including over the Internet, by telephone, by mail, or during the live webcast of the meeting. Votes can be submitted until 11:59 p.m. Eastern Time on July 18, 2024. The company has engaged Laurel Hill Advisory Group, LLC to assist stockholders with voting and inquiries. NexImmune's management has expressed appreciation for stockholders' prompt attention and continued confidence.